Feasibility and pilot randomised controlled trial of a co-designed home-based personalised reablement strategy program delivered via Voice-Controlled Intelligent Personal Assistants in older adults aged 60-89 years with mild cognitive impairment and/or dementia.

Dementia Australia Research Foundation0 sites30 target enrollmentAugust 22, 2023

ConditionsDementia Mild cognitive impairment Neurological - Dementias Mental Health - Other mental health disorders

Overview

Phase: 未知
Intervention: Not specified
Conditions: Dementia
Sponsor: Dementia Australia Research Foundation
Enrollment: 30
Status: Active, not recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

August 22, 2023

End Date

TBD

Last Updated

last year

Study Type

Interventional

Sex

All

Investigators

Sponsor

Dementia Australia Research Foundation

Eligibility Criteria

Inclusion Criteria

•Prospective participants must meet the following criteria including English\-speaking, aged 60\-89 years, reside anywhere in Australia, have a recent (less than 6 months) clinical diagnosis of early dementia (any type) or MCI by a Cognitive, Dementia and Memory Service (CDAMS) Clinic, Neuropsychologist or General Practitioner; have a home Wi\-Fi network and smart devices and have a primary carer with at least 50% close contact during the 12\-week period.

Exclusion Criteria

•Participants will be ineligible if they report currently being unable to walk across a room unaided; are non\-English speaking or have difficulty communicating with study personnel or a VIPA device due to speech or hearing problems; unwilling to be randomised; planning to be away from the VIPA device is greater than 4 weeks during the 12\-week intervention period; any disorder of such severity that life expectancy is less than 12 months, or any cognitive or physical impairment or disability that in the opinion of the study investigators would result in the participant having difficulty interacting with Buddy Link or performing personalized reablement program safely. These include
•\- Progressive neurological disorders including Parkinson’s Disease and multiple sclerosis;
•\- Schizophrenia, other psychotic disorders, bipolar disorder;
•\- Severe knee or hip arthritis that would interfere with ability to complete functional tests and the intervention;
•\- Lung disease requiring regular use of supplemental oxygen
•\- Renal disease requiring dialysis;
•\- Hyper\- or hypothyroidism;
•\- Cardiovascular disease (including New York Heart Association (NYHA) Class III or IV congestive heart failure, clinically significant valvular disease, history of cardiac arrest, presence of an implantable cardiac defibrillator, or uncontrolled angina)
•\- Other disorder of such severity that life expectancy is less than 12 months;
•\- Stroke, hip or knee replacement, spinal surgery, myocardial infarction or major heart surgery in the past 6 months.